GNLX revenueFY2025$8.0K
- FY YoY
- +0.0%
GNLX revenue was $8.0K for fiscal 2025 (ended Dec 31, 2025), up 0.0% from fiscal 2024. It rose in 0 of the last 3 fiscal years.
Genelux Corporation (GNLX) financials
For fiscal 2025 (ended Dec 31, 2025), Genelux Corporation reported $8.0K of revenue and -$32.15M of net income.
- Revenue, FY2025
- $8.0K
- Revenue growth, YoY
- +0.0%
- Net income, FY2025
- -$32.15M
- Net margin
- -401812.5%
- Free cash flow, FY2025
- -$26.37M
- EPS, diluted, FY2025
- -$0.86
- Cash
- $9.18M
- P/S
- 10576.10
- Market cap
- $84.6M
FY2022FY2025
FY2022FY2025
FY2022FY2025
GNLX revenue and earnings growth
GNLX net incomeQ2 2026-$9.47M
GNLX net income was -$9.47M in fiscal Q2 2026 (ended Jun 30, 2026), compared with -$7.46M a year earlier. For the full fiscal 2025 it was -$32.15M, compared with -$29.87M in fiscal 2024.
GNLX EPSQ2 2026-$0.21
GNLX diluted EPS was -$0.21 in fiscal Q2 2026 (ended Jun 30, 2026), compared with -$0.20 a year earlier. For the full fiscal 2025 it was -$0.86, compared with -$0.95 in fiscal 2024.
GNLX free cash flowQ2 2026-$7.98M
GNLX free cash flow was -$7.98M in fiscal Q2 2026 (ended Jun 30, 2026), compared with -$7.17M a year earlier. For the full fiscal 2025 it was -$26.37M, compared with -$21.61M in fiscal 2024.
Income statement
| Line item | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 |
|---|---|---|---|---|
| Revenue | $8.0K | $8.0K | $170.0K | $11.07M |
| Research and development | $19.85M | $19.00M | $12.77M | $9.08M |
| Selling, general and admin | $13.37M | $12.71M | $11.57M | $5.00M |
| Operating income | -$33.21M | -$31.70M | -$24.16M | -$3.01M |
| Interest expense | - | - | $173.0K | - |
| Income tax | - | - | - | $1.10M |
| Net income | -$32.15M | -$29.87M | -$28.30M | -$5.21M |
| EPS, basic | -$0.86 | -$0.95 | -$1.16 | -$0.57 |
| EPS, diluted | -$0.86 | -$0.95 | -$1.16 | -$0.57 |
| Diluted shares | 37.2M | 31.5M | 24.4M | 9.1M |
Balance sheet
| Line item | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 |
|---|---|---|---|---|
| Cash and equivalents | $5.33M | $8.56M | $9.42M | $397.0K |
| Short-term investments | - | $22.33M | $13.77M | - |
| Current assets | $15.13M | $31.55M | $24.20M | $1.89M |
| Total assets | $19.03M | $34.72M | $27.89M | $5.53M |
| Current liabilities | $6.22M | $6.90M | $6.55M | $31.63M |
| Short-term debt | - | - | $900.0K | - |
| Total liabilities | $7.48M | $8.44M | $8.42M | $41.31M |
| Shareholders' equity | $11.54M | $26.27M | $19.47M | -$35.78M |
Cash flow
| Line item | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 |
|---|---|---|---|---|
| Operating cash flow | -$25.27M | -$21.23M | -$20.27M | -$3.57M |
| Capital expenditures | $1.10M | $381.0K | $1.02M | $49.0K |
| Free cash flow | -$26.37M | -$21.61M | -$21.30M | -$3.62M |
| Investing cash flow | $12.14M | -$8.13M | -$14.72M | -$49.0K |
| Financing cash flow | $9.89M | $28.51M | $44.02M | -$478.0K |
| Stock-based compensation | $5.87M | $5.74M | $2.52M | $2.42M |
Key ratios
| Line item | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 |
|---|---|---|---|---|
| Revenue growth, YoY | 0.0% | -95.3% | -98.5% | - |
| Operating margin | -415175.0% | -396200.0% | -14214.7% | -27.2% |
| Net margin | -401812.5% | -373362.5% | -16645.3% | -47.0% |
| Free cash flow margin | -329575.0% | -270112.5% | -12529.4% | -32.7% |
| Return on equity | -278.5% | -113.7% | -145.3% | - |
| Return on assets | -168.9% | -86.0% | -101.4% | -94.1% |
| Current ratio | 2.43 | 4.57 | 3.69 | 0.06 |
Income statement
| Line item | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | $0 | $0 | $0 | $8.0K | $0 | $0 |
| Research and development | $6.51M | $5.78M | $5.65M | $4.74M | $4.76M | $4.70M | $6.52M | $4.05M | $4.42M | $4.01M | $4.16M | $2.82M |
| Selling, general and admin | $3.14M | $3.39M | $3.77M | $3.45M | $3.03M | $3.12M | $3.23M | $2.89M | $2.48M | $4.11M | $2.84M | $2.49M |
| Operating income | -$9.64M | -$9.17M | -$9.41M | -$8.19M | -$7.79M | -$7.82M | -$9.75M | -$6.94M | -$6.89M | -$8.12M | -$7.00M | -$5.31M |
| Interest expense | - | - | - | - | - | - | - | - | - | - | $6.0K | - |
| Pre-tax income | - | - | - | - | - | - | - | - | - | - | - | -$5.34M |
| Net income | -$9.47M | -$8.93M | -$9.25M | -$7.95M | -$7.46M | -$7.49M | -$8.98M | -$6.47M | -$6.58M | -$7.85M | -$6.77M | -$5.34M |
| EPS, basic | -$0.21 | -$0.20 | -$0.24 | -$0.21 | -$0.20 | -$0.21 | -$0.25 | -$0.19 | -$0.22 | -$0.29 | - | -$0.20 |
| EPS, diluted | -$0.21 | -$0.20 | -$0.24 | -$0.21 | -$0.20 | -$0.21 | -$0.25 | -$0.19 | -$0.22 | -$0.29 | - | -$0.20 |
| Diluted shares | 45.0M | 44.2M | - | 37.9M | 37.9M | 34.9M | - | 34.5M | 29.7M | 26.8M | - | 26.2M |
Balance sheet
| Line item | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | $9.18M | $9.27M | $5.33M | $4.69M | $6.55M | $16.21M | $8.56M | $6.10M | $7.86M | $4.06M | $9.42M | $29.87M |
| Short-term investments | $9.50M | $16.90M | - | $16.22M | $21.43M | $18.90M | $22.33M | $27.95M | $25.78M | $15.57M | $13.77M | - |
| Current assets | $19.14M | $26.75M | $15.13M | $21.55M | $29.23M | $35.95M | $31.55M | $35.97M | $34.87M | $21.20M | $24.20M | $31.18M |
| Total assets | $26.20M | $32.37M | $19.03M | $24.99M | $32.25M | $38.98M | $34.72M | $40.27M | $45.18M | $24.68M | $27.89M | $34.07M |
| Current liabilities | $8.00M | $7.27M | $6.22M | $5.13M | $6.99M | $7.69M | $6.90M | $5.55M | $5.80M | $7.80M | $6.55M | $8.76M |
| Short-term debt | - | - | - | - | - | - | - | - | - | - | $900.0K | $900.0K |
| Total liabilities | $10.09M | $9.45M | $7.48M | $6.40M | $8.35M | $9.14M | $8.44M | $7.18M | $7.51M | $9.59M | $8.42M | $10.04M |
| Shareholders' equity | $16.11M | $22.92M | $11.54M | $18.59M | $23.90M | $29.85M | $26.27M | $33.09M | $37.67M | $15.08M | $19.47M | $24.03M |
Cash flow
| Line item | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -$6.44M | -$6.06M | -$6.20M | -$6.58M | -$7.06M | -$5.43M | -$4.30M | -$5.75M | -$6.82M | -$4.35M | -$6.91M | -$3.36M |
| Capital expenditures | $1.53M | $921.0K | $436.0K | $517.0K | $115.0K | $30.0K | $96.0K | $27.0K | $228.0K | $30.0K | $243.0K | $277.0K |
| Free cash flow | -$7.98M | -$6.98M | -$6.63M | -$7.09M | -$7.17M | -$5.46M | -$4.40M | -$5.78M | -$7.05M | -$4.38M | -$7.15M | -$3.63M |
| Investing cash flow | $5.97M | -$8.54M | $6.56M | $4.72M | -$2.65M | $3.51M | $6.67M | $3.99M | -$17.11M | -$1.69M | -$13.94M | -$277.0K |
| Financing cash flow | $387.0K | $18.54M | $276.0K | $0 | $52.0K | $9.57M | $91.0K | $0 | $27.73M | $688.0K | $401.0K | $6.36M |
| Stock-based compensation | - | $1.39M | $1.53M | $1.62M | $1.29M | $1.42M | $1.43M | $1.52M | $1.30M | $1.49M | $1.53M | $515.0K |
Key ratios
| Line item | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue growth, YoY | - | - | - | - | - | - | - | - | - | -95.3% | -100.0% | -100.0% |
| Operating margin | - | - | - | - | - | - | - | - | - | -101437.5% | - | - |
| Net margin | - | - | - | - | - | - | - | - | - | -98125.0% | - | - |
| Free cash flow margin | - | - | - | - | - | - | - | - | - | -54800.0% | - | - |
| Current ratio | 2.39 | 3.68 | 2.43 | 4.20 | 4.18 | 4.67 | 4.57 | 6.47 | 6.01 | 2.72 | 3.69 | 3.56 |
Source: XBRL data Genelux Corporation files with the SEC, latest filing dated Aug 13, 2026 (see filings on SEC EDGAR). Provided for information only, not investment advice. Check the filing before relying on a number.
* Worked out from the filings rather than stated in them: Q4 is the full year less the first nine months.
Per-share figures are as filed. The filings show no stock split in these periods.
EPS growth is left out where the share count moved enough to suggest a split the filings do not show. Growth rates need a positive starting figure. CAGR is compound annual growth between fiscal years. The CSV holds every period on file, in full figures, from the same SEC filings.
GNLX peers
| Company | Revenue | Growth | Net income | Net margin | Market cap |
|---|---|---|---|---|---|
| GNLX | $8.0K | +0.0% | -$32.15M | -401812.5% | $84.6M |
| LLY | $86.46B | +45.5% | $27.58B | 31.9% | $1.36T |
| JNJ | $99.33B | +7.8% | $16.09B | 16.2% | $687.89B |
| ABBV | $66.01B | +10.7% | $10.34B | 15.7% | $521.50B |
| MRK | $67.38B | +4.9% | $2.45B | 3.6% | $364.26B |
| NVS | $54.53B | +8.4% | $13.98B | 25.6% | $306.26B |
| AZN | $58.74B | +8.6% | $10.22B | 17.4% | $286.03B |
| ABT | $48.23B | +10.0% | $4.70B | 9.7% | $187.95B |
| NVO | DKK 309.06B | +6.4% | DKK 102.43B | 33.1% | $184.33B |
GNLX FAQ
8 questionsWhat is GNLX revenue?
Genelux Corporation (GNLX) reported $8.0K of revenue for fiscal 2025 (ended Dec 31, 2025). That is up 0.0% from the year before.Is GNLX profitable?
No. Genelux Corporation reported a net loss of $32.15M for fiscal 2025 (ended Dec 31, 2025).How much cash and debt does GNLX have?
Genelux Corporation reported $9.18M in cash and cash equivalents on its most recent balance sheet in SEC filings.How fast is GNLX revenue growing?
Genelux Corporation's revenue changed +0.0% in fiscal 2025, to $8.0K.What is GNLX free cash flow?
Genelux Corporation generated -$26.37M of free cash flow for fiscal 2025 (ended Dec 31, 2025), which is operating cash flow of -$25.27M less capital expenditures.What is GNLX earnings per share?
Diluted earnings per share were -$0.86 for fiscal 2025 (ended Dec 31, 2025), from SEC filings, restated for any stock split those filings show.When did GNLX last report financial results?
The latest statements here come from Genelux Corporation's 10-Q filed on Aug 13, 2026, covering the period ended Jun 30, 2026.Where does this GNLX financial data come from?
Quantisnow builds these statements from the structured XBRL data Genelux Corporation files with the SEC. It is provided for information only and is not investment advice.